{{Rsnum
|rsid=2606345
|Gene=CYP1A1
|Chromosome=15
|position=74724835
|Orientation=plus
|GMAF=0.3352
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=CYP1A1
}}{{PMID|18415690}} 577 testicular germ cell tumors cases (254 seminoma, 323 nonseminoma) and 707 controls. 

inversely associated with nonseminoma: 
*[[rs4886605]] OR = 0.75 (95% CI = 0.54-1.04) among the heterozygotes and OR = 0.37, 95% CI = 0.12-1.11 among the homozygotes with a p-value for trend = 0.02; 
*[[rs2606345]] OR = 0.69 (95% CI = 0.51-0.93) among heterozygotes and OR = 0.70 (95% CI = 0.42-1.17) among homozygotes, with a p-value for trend = 0.02.

{{PMID Auto
|PMID=19168589
|Title=Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China
|OA=1
}}
{{PMID Auto
|PMID=19479063
|Title=Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression
|OA=1
}}

{{PMID Auto
|PMID=19630952
|Title=Sex steroid metabolism polymorphisms and mammographic density in pre- and early peri-menopausal women
|OA=1
}}

{{PMID Auto
|PMID=16949383
|Title=Sex steroid hormone pathway genes and health-related measures in women of 4 races/ethnicities: the Study of Women's Health Across the Nation (SWAN).
}}

{{PMID Auto
|PMID=16949388
|Title=CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal.
}}

{{PMID Auto
|PMID=16949389
|Title=Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors.
}}

{{PMID Auto
|PMID=16949393
|Title=Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife.
}}

{{PMID Auto
|PMID=18268125
|Title=Assessment of interactions between PAH exposure and genetic polymorphisms on PAH-DNA adducts in African American, Dominican, and Caucasian mothers and newborns.
|OA=1
}}

{{PMID Auto
|PMID=18579753
|Title=Vascular actions of estrogens: functional implications.
|OA=1
}}

{{PMID Auto
|PMID=18632753
|Title=Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
|OA=1
}}

{{PMID Auto
|PMID=18691756
|Title=Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk.
|OA=1
}}

{{PMID Auto
|PMID=18936436
|Title=Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994.
|OA=1
}}

{{PMID Auto
|PMID=19330903
|Title=Gene by smoking interaction in hypertension: identification of a major quantitative trait locus on chromosome 15q for systolic blood pressure in Mexican-Americans.
|OA=1
}}

{{PMID Auto
|PMID=22569204
|Title=PharmGKB summary: phenytoin pathway.
|OA=1
}}

{{PMID Auto
|PMID=23411129
|Title=Functional polymorphisms in the CYP1A1, ACE, and IL-6 genes contribute to susceptibility to community-acquired and nosocomial pneumonia
}}

{{PMID Auto
|PMID=23107763
|Title=Host genetic risk factors for community-acquired pneumonia.
}}

{{PMID Auto
|PMID=23661361
|Title=The potential effect of gender in CYP1A1 and GSTM1 genotype-specific associations with pediatric brain tumor.
}}

{{PMID Auto
|PMID=24068433
|Title=CYP1A1, GCLC, AGT, AGTR1 gene-gene interactions in community-acquired pneumonia pulmonary complications
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}